Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Investigating low frequency somatic mutations in Arabidopsis with Duplex Sequencing

PROVIDER: PRJNA1065470 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27564102_1.fastq.gz	Fastqsanger.gz
	SRR27564102_2.fastq.gz	Fastqsanger.gz
	SRR27564103_1.fastq.gz	Fastqsanger.gz
	SRR27564103_2.fastq.gz	Fastqsanger.gz
	SRR27564104_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 72

Similar Datasets

Project description:Accurate Detection of Somatic Mutations Using Duplex Sequencing with Comprehensive Genome Coverage -- CompDuplex-seq

| PRJNA1090006 | ENA

Human immunodeficiency virus 1

Project description:HIV low frequency drug resistance mutations on naive patients

| PRJNA209812 | ENA

Project description:Duplex sequencing to detect de novo mitochondrial and plastid mutations in Arabidopsis thaliana

| PRJNA604956 | ENA

Project description:Fragment Enrichment of Circulating Tumor DNA with Low-Frequency Mutations

| PRJNA562379 | ENA

Project description:Duplex sequencing mouse mtDNA (somatic tissues and oocytes)

| PRJNA563921 | ENA

Project description:Duplex sequencing human mtDNA (somatic tissues and oocytes)

| PRJNA1181658 | ENA

Transcription profiling by array of Arabidopsis seedlings response to three oscillating levels in cytosolic Ca2+

Project description:Comparison of 3 oscillating elevations in cytosolic Ca2+ (created using electrical stimulation and measured using aequorin luminescence) in Arabidopsis seedlings. Treatment 1; high frequency high amplitude osc., Treatment 2; high frequency low amplitude osc., Treatment 3; low frequency low amplitude osc. One biological sample per experiment processed as technical dye swaps against intreated control.

2010-08-01 | E-MEXP-2663 | biostudies-arrayexpress

Identification and characterization of mutations in ZBTB33 in clonal hematopoiesis and myelodysplastic syndromes

Project description:Beauchamp EM, Leventhal M, Bernard E, Hoppe ER, Todisco G, Creignou M, Galli A, Castellano CA, McConkey M, Tarun A, Wong W, Schenone M, Stanclift C, Tanenbaum B, Malolepsza E, Nilsson B, Bick AG, Weinstock JS, Miller M, Niroula A, Dunford A, Taylor-Weiner A, Wood T, Barbera A, Anand S, Psaty BM, Desai P, Cho MH, Johnson AD, Loos R, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, DMacArthur DG, Lek M, Exome Aggregation Consortium, Neuberg DS, Lage K, Carr SA, Hellstrom-Lindberg E, Malcovati L, Papaemmanuil E, Stewart C, Getz G, Bradley RK, Jaiswal S, Ebert BL. 2021. Clonal hematopoiesis results from somatic mutations in cancer driver genes in hematopoietic stem cells. We sought to identify novel drivers of clonal expansion using an unbiased analysis of sequencing data from 84,683 persons and identified common mutations in the 5-methylcytosine reader, ZBTB33, as well as in YLPM1, SRCAP, and ZNF318. We also identified these mutations at low frequency in myelodysplastic syndrome patients. Zbtb33 edited mouse hematopoietic stem and progenitor cells exhibited a competitive advantage in vivo and increased genome-wide intron retention. ZBTB33 mutations are potentially linked to DNA methylation and RNA splicing, the two most commonly mutated pathways in clonal hematopoiesis and MDS.

2021-04-26 | MSV000087304 | MassIVE

Project description:Duplex sequencing rhesus macaque mtDNA (somatic tissues and oocytes)

| PRJNA777828 | ENA

Intra-individual genomic heterogeneity of ovarian serous adenocarcinoma [Agilent]

Project description:Intra-individual tumoral heterogeneity (ITH) is a hallmark of solid tumors and impedes accurate genomic diagnosis and selection of proper therapy. The purpose of this study was to identify ITH of ovarian serous adenocarcinomas (OSAs) and to determine the utility of ascitic cancer cells as a resource for mutation profiling in spite of ITH. We performed whole-exome sequencing, copy number profiling, and DNA methylation profiling of four OSA genomes using multiregional biopsies from 13 intraovarian lesions, 12 extraovarian tumor lesions (omentum/peritoneum), and ascitic cells. We observed substantial levels of heterogeneity in mutations and copy number alterations (CNAs) of the OSAs. We categorized the mutations into 'common', 'shared' and 'private' according to the regional distribution. Six common, 8 shared, and 24 private mutations were observed in known cancer-related genes,. but common mutations had a higher mutant allele frequency and included TP53 mutations in all four OSAs. Region-specific chromosomal amplifications and deletions involving BRCA1, PIK3CA, and RB1 were also identified. Of note, the mutations detected in ascitic cancer cells represented 92.3-100% of overall somatic mutations in the given case. Phylogenetic analyses of ascitic genomes predicted a polyseeding origin of somatic mutations in ascitic cells. Our results demonstrate that despite ITH, somatic mutations, CNAs, and DNA methylations in both “common” category and cancer-related genes were highly conserved in ascitic cells of OSAs, highlighting the clinical relevance of genome analysis of ascitic cells. Ascitic tumor cells may serve as a potential resource to discover somatic mutations of primary OSA with diagnostic and therapeutic relevance.

2016-08-09 | GSE85295 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data